Latest Health News

Thrive Tribe Technologies (ASX:1TT) is issuing approximately 116.87 million Loyalty Options to shareholders at no cost, exercisable at $0.003 each and expiring in 2029, aiming to reward loyalty and potentially raise capital upon exercise.

Cleo Diagnostics has laid out a clear U.S. reimbursement pathway for its ovarian cancer test, leveraging an existing CPT code to enable early market entry and data collection ahead of FDA clearance.

EBR Systems has locked in a three-year purchasing agreement with CHRISTUS Health, the ninth-largest US hospital network, to advance its WiSE CRT System's US rollout across 66 hospitals.

Metgasco has obtained a A$500,000 bridging loan at 10% interest to cover immediate capital needs while advancing a broader debt restructuring plan.

Catapult Sports Ltd (ASX:CAT) delivered a 20.8% revenue increase to US$140.7 million in FY26, driven by strong SaaS growth and strategic acquisitions, while management EBITDA surged 67%. Despite this, the company reported a net loss of US$24 million, impacted by non-cash expenses and acquisition costs.

Smartgroup posted robust 2025 results with record customer growth and accelerated EV leasing, backed by strategic digital investments and a $20 million share buy-back plan following fleet portfolio sales.

Sheffield Resources has secured an additional US$10.15 million tranche on its senior loan facility for the Thunderbird Mineral Sands Mine, aimed at bolstering working capital. Ongoing negotiations to restructure debt add an element of financial uncertainty for the joint venture.

Geopacific Resources' updated 2026 DFS for the Woodlark Gold Project reveals a 19% rise in Mineral Resources to 1.98 million ounces and a new Ore Reserve of 1.2 million ounces, underpinning robust economics and a rapid 18-month payback.

Brisbane Broncos capped a landmark 2025 season with both NRL and NRLW premiership victories, driving a 20.5% revenue surge and a 36% profit increase. The club rewarded shareholders with increased dividends amid record crowds and expanded community programs.

Island Pharmaceuticals has appointed Mark Herzog as Senior Global Health Security Advisor and secured roles in key Medical Countermeasures Coalition groups, boosting its US biodefence engagement ahead of pivotal Galidesivir Animal Rule studies.

Electro Optic Systems (ASX:EOS) has launched a A$175 million capital raising to complete its MARSS acquisition and accelerate expansion in counter-drone and defence technologies, buoyed by a surge in Middle East orders.

Vitasora has launched its proprietary vCare EMR platform, cutting SaaS costs by over 90% and nearly doubling patient enrolments in April. The company targets cashflow breakeven in H2 2026 as enrolment momentum builds.